Artículo

Estamos trabajando para incorporar este artículo al repositorio
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor

Abstract:

Apoptosis of thymic cells induced by glucocorticoids (GC) and T-cell receptor (TCR) engagement are mutually antagonistic. We demonstrate that cAMP enhances GC and antagonizes TCR (anti-CD3) apoptosis on the same cell (DO-11.10 and 2B4.11 T-cell hybridomas). We analyzed the activity of several transcription factors in this cAMP dual, stimulus-dependent, regulatory action. Anti-CD3 increases kB-activity which is inhibited by CPTcAMP or dexamethasone (DEX), supporting the proapoptotic role of NFkB on TCR-induced apoptosis. Anti-CD3 not only increases kB- but diminishes GC response element (GRE)-activity induced by DEX, suggesting that TCR-mediated blockade of GC-induced apoptosis involves not only the proposed antiapoptotic action of NF-kB on GC, but also the inhibition of GRE-regulated proapoptotic genes. To test the involvement of CRE-driven transcription in the cAMP dual apoptotic regulation, cells were transfected with a CRE decoy DNA oligomer. Blockade of CRE transactivation with decoy targeting of CRE completely blocked the protection of TCR-induced apoptosis by cAMP, while it did not modify the enhancement by cAMP on GC-induced apoptosis. We show that CRE-binding factors have a definite role in T-cell apoptosis: they are involved in cAMP protection of TCR- but not in cAMP potentiation of GC-induced apoptosis. © 2002 Elsevier Science B.V. All rights reserved.

Registro:

Documento: Artículo
Título:CRE-Mediated transcriptional activation is involved in cAMP protection of T-cell receptor-induced apoptosis but not in cAMP potentiation of glucocorticoid-mediated programmed cell death
Autor:Igaz, L.M.; Refojo, D.; Costas, M.A.; Holsboer, F.; Arzt, E.
Filiación:Laboratorio de Fisiologı́a y Biologı́a Molecular, Departamento de Biologı́a, FCEN, Universidad de Buenos Aires, Ciudad Universitaria, Pabellon II, 1428 Buenos Aires, Argentina
Max-Planck Institute of Psychiatry, Kraepelinstrasse 2-10, 80804 Munich, Germany
Palabras clave:Apoptosis; CAMP responsive element binding protein; Cyclic AMP; Glucocorticoids; T cell receptor; bucladesine; CD3 antigen; cyclic AMP; cyclic AMP responsive element binding protein; dexamethasone; DNA; glucocorticoid; immunoglobulin enhancer binding protein; monoclonal antibody CD3; oligomer; T lymphocyte receptor; animal cell; apoptosis; article; controlled study; cyclic AMP responsive element; enzyme activity; enzyme inhibition; genetic transfection; hybridoma cell culture; mouse; nonhuman; priority journal; regulatory mechanism; T lymphocyte; transcription initiation; Animals; Apoptosis; Cell Line; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Flow Cytometry; Glucocorticoids; Hybridomas; Mice; Receptors, Antigen, T-Cell; Response Elements; T-Lymphocytes; Transcription, Genetic; Transfection
Año:2001
Volumen:1542
Número:1-3
Página de inicio:139
Página de fin:148
DOI: http://dx.doi.org/10.1016/S0167-4889(01)00174-4
Título revista:Biochimica et Biophysica Acta - Molecular Cell Research
Título revista abreviado:Biochim. Biophys. Acta Mol. Cell Res.
ISSN:01674889
CAS:Cyclic AMP Response Element-Binding Protein; Cyclic AMP, 60-92-4; Glucocorticoids; Receptors, Antigen, T-Cell
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01674889_v1542_n1-3_p139_Igaz

Referencias:

  • Smith, C.A., Williams, G.T., Kingston, R., Jenkinson, E.J., Owen, J.J., (1989) Nature, 337, pp. 181-184
  • Shi, Y.F., Bissonnette, R.P., Parfrey, N., Szalay, M., Kubo, R.T., Green, D.R., (1991) J. Immunol., 146, pp. 3340-3346
  • Ucker, D.S., (1987) Nature, 327, pp. 62-64
  • Shi, Y.F., Szalay, M.G., Paskar, L., Sahai, B.M., Boyer, M., Singh, B., Green, D.R., (1990) J. Immunol., 144, pp. 3326-3333
  • Vacchio, M.S., Papadopoulos, V., Ashwell, J.D., (1994) J. Exp. Med., 179, pp. 1835-1846
  • Compton, M.M., Cidlowski, J.A., (1987) J. Biol. Chem., 262, pp. 8288-8292
  • Compton, M.M., Caron, L.A.M., Cidlowski, J.A., (1987) J. Steroid Biochem., 27, pp. 201-208
  • Gruber, J., Sgonc, R., Hu, Y.H., Beug, H., Wick, G., (1994) Eur. J. Immunol., 24, pp. 1115-1121
  • Zacharchuk, C.M., Mercep, M., June, C.H., Weissman, A.M., Ashwell, J.D., (1991) J. Immunol., 147, pp. 460-465
  • Iwata, M., Hanaoka, S., Sato, K., (1991) Eur. J. Immunol., 21, pp. 643-648
  • Zacharchuk, C.M., Mercep, M., Chakraborti, P., Simons, S.S., Ashwell, J.D., (1990) J. Immunol., 145, pp. 4037-4045
  • Iwata, M., Ohoka, Y., Kuwata, T., Asada, A., (1996) Stem Cells, 14, pp. 632-641
  • Lanotte, M., Riviere, J.B., Hermouet, S., Houge, G., Vintermyr, O.K., Gjertsen, B.T., Doskeland, S.O., (1991) J. Cell Physiol., 146, pp. 73-80
  • Lalli, E., Sassone-Corsi, P., Ceredig, R., (1996) EMBO J., 15, pp. 528-537
  • McConkey, D.J., Orrenius, S., Jondal, M., (1990) J. Immunol., 145, pp. 1227-1230
  • Hoshi, S., Furutani-Seiki, M., Seto, M., Tada, T., Asano, Y., (1994) Int. Immunol., 6, pp. 1081-1089
  • Ivanov, V.N., Lee, R.L., Podack, E.R., Malek, T.R., (1997) Oncogene, 14, pp. 2455-2464
  • Lee, M., Liou, M., Liou, M., Yang, Y., Lai, M., (1993) J. Immunol., 151, pp. 5208-5217
  • Brindle, P.K., Montminy, M.R., (1997) Curr. Opin. Genet. Dev., 2, pp. 199-207
  • Baldwin, A.S., Jr., (1996) Annu. Rev. Immunol., 14, pp. 649-683
  • Beato, M., (1989) Cell, 56, pp. 335-344
  • Vacca, A., Felli, M., Farina, A., Martinotti, S., Maroder, M., Screpanti, I., Meco, D., Frati, L., (1992) J. Exp. Med., 17, pp. 637-646
  • Auphan, N., DiDonato, J.A., Rosette, C., Helmberg, A., Karin, M., (1995) Science, 270, pp. 286-290
  • Ray, A., Prefrontaine, K.E., (1994) Proc. Natl. Acad. Sci. USA, 91, pp. 752-756
  • Scheinman, R.I., Cogswell, P.C., Lofquist, A.K., Baldwin, A.S., Jr., (1995) Science, 270, pp. 283-286
  • Costas, M., Trapp, T., Paez Pereda, M., Sauer, J., Rupprecht, R., Nahmod, V.E., Reul, J.M.H.M., Arzt, E., (1996) J. Clin. Invest., 98, pp. 1409-1416
  • Dong, Y., Aronsson, M., Gustafsson, J.-A., Okret, S., (1989) J. Biol. Chem., 264, pp. 13679-13683
  • Gruol, D.J., Rajah, F.M., Bourgeois, S., (1989) Mol. Endocrinol., 3, pp. 2119-2127
  • Haske, T., Nakao, M., Moudgil, V.K., (1994) Mol. Cell. Biochem., 132, pp. 163-171
  • Walton, M., Woodgate, A.M., Muravlev, A., Xu, R., During, M.J., Dragunow, M., (1999) J. Neurochem., 73, pp. 1836-1842
  • Saeki, K., Yuo, A., Suzuki, E., Yazaki, Y., Takaku, F., (1999) Biochem. J., 343, pp. 249-255
  • Lipton, S., (1997) Nat. Med., 3, pp. 20-21
  • Costas, M.A., Müller Igaz, L., Holsboer, F., Arzt, E., (2000) Biochim. Biophys. Acta, 1499, pp. 122-129
  • Kovalovsky, D., Paez Pereda, M., Sauer, J., Perez Castro, C., Nahmod, V.E., Stalla, G.K., Holsboer, F., Arzt, E., (1998) Eur. J. Immunol., 28, pp. 2075-2085
  • Hollemberg, S.M., Evans, R.M., (1988) Cell, 55, pp. 899-906
  • McKean, D.J., Bell, M., Huntoon, C., Rastogi, S., Van Norstrand, M., Podzorski, R., Nilson, A., Paya, C., (1995) Int. Immunol., 7, pp. 9-20
  • Kühnel, B., Buetti, E., Diggelmann, H., (1986) J. Mol. Biol., 190, pp. 367-378
  • Spengler, D., Rupprecht, R., Van, L.P., Holsboer, F., (1992) Mol. Endocrinol., 11, pp. 1931-1941
  • Lin, B., Williams-Skipp, C., Tao, Y., Schieicher, M.S., Cano, L.L., Duke, R.C., Scheinman, R.I., (1999) Cell Death Differ., 6, pp. 570-582
  • Bradford, M.M., (1976) Anal. Biochem., 72, pp. 248-254
  • Wang, J.M., Chao, J.R., Chen, W., Kuo, M.L., Yen, J.J., Yang-Yen, H.F., (1999) Mol. Cell. Biol., 19, pp. 6195-6206
  • Cui, H., Matsui, K., Omura, S., Schauer, S.L., Matulka, R.A., Sonenshein, G.E., Ju, S.-T., (1997) Proc. Natl. Acad. Sci. USA, 94, pp. 7515-7520
  • Jamieson, C.A.M., Yamamoto, K.R., (2000) Proc. Natl. Acad. Sci. USA, 97, pp. 7319-7324
  • Wu, M., Lee, H., Bellas, R., Schauer, S., Arsura, M., Katz, D., Fitzgerald, M.T., Sonenshein, G.E., (1996) EMBO J., 15, pp. 4682-4690
  • Beg, A.A., Sha, W.C., Bronson, R.T., Baltimore, D., (1995) Genes Dev., 9, pp. 2736-2746
  • Kasibhatla, S., Genestier, L., Green, D.R., (1999) J. Biol. Chem., 274, pp. 987-992
  • Reichardt, H.M., Kaestner, K.H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schütz, G., (1998) Cell, 93, pp. 531-541
  • Parry, G.C.N., Mackman, N., (1997) J. Immunol., 157, pp. 5450-5456
  • Ollivier, V., Parry, G.C.N., Cobb, R.R., De Prost, D., Mackman, N., (1996) J. Biol. Chem., 271, pp. 20828-20835
  • Hsu, S.-C., Gavrilin, M.A., Lee, H.-H., Cwu, C., Han, S.-H., Lai, M.-Z., (1999) Eur. J. Immunol., 29, pp. 2948-2956
  • Lomo, J., Blomhoff, H.K., Beiske, K., Stokke, T., Smeland, E.B., (1995) J. Immunol., 154, pp. 1634-1643
  • Han, Z., Chatterjee, D., Early, J., Pantaris, P., Hendrickson, E.A., Wyche, J.H., (1996) Cancer Res., 56, pp. 1621-1628
  • Deckworth, T.L., Johnson, E.M., Jr., (1993) J. Cell Biol., 123, pp. 1207-1222
  • Flaws, J.A., DeSanti, A., Tilly, K.I., Javid, R.O., Kugu, K., Johnson, A.L., Hirschfield, A.N., Tilly, J.L., (1995) Endocrinology, 136, pp. 4351-4359
  • Goetzl, E.J., An, S., Zeng, L., (1995) J. Immunol., 154, pp. 1041-1047
  • Barton, K., Muthusamy, N., Hanyagam, M., Fischer, C., Clendenin, C., Leiden, J.M., (1996) Nature, 379, pp. 81-85
  • Rudolph, D., Tafuri, A., Gass, P., Hämmerling, G.J., Arnold, B., Schütz, G., (1998) Proc. Natl. Acad. Sci. USA, 95, pp. 4481-4486
  • Von Knethen, A., Brockhaus, F., Kleiter, I., Brune, B., (1999) Mol. Med., 5, pp. 672-684
  • Wilson, B.E., Mochon, E., Boxer, L.M., (1996) Mol. Cell. Biol., 16, pp. 5546-5556
  • Bulloch, K., Pomerantz, W., (1984) J. Comp. Neurol., 228, pp. 57-68
  • Williams, J.M., Peterson, R.G., Shea, P.A., Schmedtje, J.F., Bauer, D.C., Felten, D.L., (1981) Brain Res. Bull., 1, pp. 83-94

Citas:

---------- APA ----------
Igaz, L.M., Refojo, D., Costas, M.A., Holsboer, F. & Arzt, E. (2001) . CRE-Mediated transcriptional activation is involved in cAMP protection of T-cell receptor-induced apoptosis but not in cAMP potentiation of glucocorticoid-mediated programmed cell death. Biochimica et Biophysica Acta - Molecular Cell Research, 1542(1-3), 139-148.
http://dx.doi.org/10.1016/S0167-4889(01)00174-4
---------- CHICAGO ----------
Igaz, L.M., Refojo, D., Costas, M.A., Holsboer, F., Arzt, E. "CRE-Mediated transcriptional activation is involved in cAMP protection of T-cell receptor-induced apoptosis but not in cAMP potentiation of glucocorticoid-mediated programmed cell death" . Biochimica et Biophysica Acta - Molecular Cell Research 1542, no. 1-3 (2001) : 139-148.
http://dx.doi.org/10.1016/S0167-4889(01)00174-4
---------- MLA ----------
Igaz, L.M., Refojo, D., Costas, M.A., Holsboer, F., Arzt, E. "CRE-Mediated transcriptional activation is involved in cAMP protection of T-cell receptor-induced apoptosis but not in cAMP potentiation of glucocorticoid-mediated programmed cell death" . Biochimica et Biophysica Acta - Molecular Cell Research, vol. 1542, no. 1-3, 2001, pp. 139-148.
http://dx.doi.org/10.1016/S0167-4889(01)00174-4
---------- VANCOUVER ----------
Igaz, L.M., Refojo, D., Costas, M.A., Holsboer, F., Arzt, E. CRE-Mediated transcriptional activation is involved in cAMP protection of T-cell receptor-induced apoptosis but not in cAMP potentiation of glucocorticoid-mediated programmed cell death. Biochim. Biophys. Acta Mol. Cell Res. 2001;1542(1-3):139-148.
http://dx.doi.org/10.1016/S0167-4889(01)00174-4